Case-control study of simian virus 40 and non-Hodgkin lymphoma in the United States

Journal of the National Cancer Institute

Volumn 96, Issue 18, 2004, Pages 1368-1374

  Engels, Eric A ^a   Viscidi, Raphael P ^b   Galloway, Denise A ^c   Carter, Joseph J ^c   Cerhan, James R ^d   Davis, Scott ^c   Cozen, Wendy ^e   Severson, Richard K ^f   de Sanjose, Silvia ^g   Colt, Joanne S ^a   Hartge, Patricia ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

^d MAYO CLINIC   (United States)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^f WAYNE STATE UNIVERSITY   (United States)

^g CATALAN INSTITUTE OF ONCOLOGY   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BK VIRUS; BLOOD SAMPLING; CANCER RISK; CLINICAL LABORATORY; COMPETITIVE INHIBITION; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG CONTAMINATION; ENZYME IMMUNOASSAY; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; JC VIRUS; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; RACE; SEROLOGY; SEX; SIMIAN VIRUS 40; STATISTICAL ANALYSIS; UNITED STATES; VIRUS DETECTION; VIRUS INFECTION; VIRUS PARTICLE; CANCER REGISTRY; CASE CONTROL STUDY; EPIDEMIOLOGY; GENETICS; IMMUNOLOGY; ISOLATION AND PURIFICATION; METHODOLOGY; MIDDLE AGED; VIROLOGY;

VIRUS ANTIBODY;

ADULT; AGED; ANTIBODIES, VIRAL; CASE-CONTROL STUDIES; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; POLYOMAVIRUS INFECTIONS; RESEARCH DESIGN; SEER PROGRAM; SEROEPIDEMIOLOGIC STUDIES; SIMIAN VIRUS 40; TUMOR VIRUS INFECTIONS; UNITED STATES;

EID: 4644227942     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/djh266     Document Type: Article

References (32)

1. Scherr PA, Mueller NE. Non-Hodgkin's lymphomas. In: Schottenfeld D, Fraumeni JF Jr, editors. Cancer epidemiology and prevention. 2nd ed. New York (NY): Oxford University Press; 1996. p. 920-45.
2. Rizzo P, Carbone M, Fisher SG, Matker C, Swinnen LJ, Powers A, et al. Simian virus 40 is present in most United States human mesotheliomas, but it is rarely present in non-Hodgkin's lymphoma. Chest 1999; 116:470S-3S.
3. Shivapurkar N, Harada K, Reddy J, Scheuermann RH, Xu Y, McKenna RW, et al. Presence of simian virus 40 DNA sequences in human lymphomas. Lancet 2002;359:851-2.
4. Vilchez RA, Madden CR, Kozinetz CA, Halvorson SJ, White ZS, Jorgensen JL, et al. Association between simian virus 40 and non-Hodgkin lymphoma. Lancet 2002;359:817-23.
5. David H, Mendoza S, Konishi T, Miller CW. Simian virus 40 is present in human lymphomas and normal blood. Cancer Lett 2001;162:57-64.
6. Shah K, Nathanson N. Human exposure to SV40: review and comment. Am J Epidemiol 1976;103:1-12.
7. Diamandopoulos GT. Leukemia, lymphoma, and osteosarcoma induced in the Syrian golden hamster by simian virus 40. Science 1972;176:173-5.
8. Shah KV. Polyoma viruses (JC virus, BK virus, and simian virus 40) and human cancer. In: Goedert JJ, editor. Infectious causes of cancer: targets for intervention. Totowa (NJ): Humana; 2000. p. 461-74.
9. Capello D, Rossi D, Gaudino G, Carbone A, Gaidano G. Simian virus 40 infection in lymphoproliferative disorders. Lancet 2003;361:88-9.
10. MacKenzie J, Wilson KS, Perry J, Gallagher A, Jarrett RF. Association between simian virus 40 DNA and lymphoma in the United Kingdom. J Natl Cancer Inst 2003;95:1001-3.
11. Anonymous. Immunization safety review. SV40 contamination of polio vaccine and cancer. Washington (DC): National Academy Press; 2003.
12. Shaikh S, Skoczylas C, Longnecker R, Rundell K. Inability of simian virus 40 to establish productive infection of lymphoblastic cell lines. J Virol 2004;78:4917-20.
13. Carroll-Pankhurst C, Engels EA, Strickler HD, Goedert JJ, Wagner J, Mortimer EA Jr. Thirty-five year mortality following receipt of SV40-contaminated polio vaccine during the neonatal period. Br J Cancer 2001; 85:1295-7.
14. Engels EA, Katki HA, Nielsen NM, Winther JF, Hjalgrim H, Gjerris F, et al. Cancer incidence in Denmark following exposure to poliovirus vaccine contaminated with simian virus 40. J Natl Cancer Inst 2003;95:532-9.
15. Engels EA, Rodman LH, Frisch M, Goedert JJ, Biggar RJ. Childhood exposure to simian virus 40-contaminated poliovirus vaccine and risk of AIDS-associated non-Hodgkin's lymphoma. Int J Cancer 2003;106:283-7.
16. Carter JJ, Madeleine MM, Wipf GC, Garcea RL, Pipkin PA, Minor PD, et al. Lack of serologic evidence for prevalent simian virus 40 infection in humans. J Natl Cancer Inst 2003;95:1522-30.
17. de Sanjose S, Shah KV, Domingo-Domenech E, Engels EA, Fernandez de Sevilla A, Alvaro T, et al. Lack of serological evidence for an association between simian virus 40 and lymphoma. Int J Cancer 2003;104:522-4.
18. Engels EA, Chatterjee N, Cerhan JR, Davis S, Cozen W, Severson RK, et al Hepatitis C virus infection and non-Hodgkin lymphoma: results of the NCI-SEER multi-center case-control study. Int J Cancer 2004;111:76-80.
19. Anonymous. International classification of diseases for oncology. 2nd ed. Geneva (Switzerland): World Health Organization; 1990.
20. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JK, Cleary ML, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994;84: 1361-92.
21. Viscidi RP, Rollison DE, Viscidi E, Clayman B, Rubalcaba E, Daniel R, et al. Serological cross-reactivities between antibodies to simian virus 40, BK virus, and JC virus assessed by virus-like-particle-based enzyme immuno-assays. Clin Diagn Lab Immunol 2003;10:278-85.
22. Nakatsuka S, Liu A, Dong Z, Nomura S, Takakuwa T, Miyazato H, et al. Simian virus 40 sequences in malignant lymphomas in Japan. Cancer Res 2003;63:7606-8.
23. Martini F, Dolcetti R, Gloghini A, Iaccheri L, Carbone A, Boiocchi M, et al. Simian-virus-40 footprints in human lymphoproliferative disorders of HIV- and HIV+ patients. Int J Cancer 1998;78:669-74.
24. Cicala C, Pompetti F, Carbone M. SV40 induces mesotheliomas in hamsters. Am J Pathol 1993;142:1524-33.
25. Fredericks DN, Relman DA. Sequence-based identification of microbial pathogens: a reconsideration of Koch's postulates. Clin Microbiol Rev 1996;9:18-33.
26. Brown P, Tsai T, Gajdusek C. Seroepidemiology of human papovaviruses. Discovery of virgin populations and some unusual patterns of antibody prevalence among remote peoples of the world. Am J Epidemiol 1975; 102:331-40.
27. Brown P, Morris JA. Serologic response to BK virus following human infection with SV40. Proc Soc Exp Biol Med 1976;152:130-1.
28. Magrath DI, Russell K, Tobin JO. Vacuolating agent. BMJ 1961;2:287-8.
29. Gerber P. Patterns of antibodies to SV40 in children following the last booster with inactivated poliomyelitis vaccines. Proc Soc Exp Biol Med 1967;125:1284-7.
30. Shah KV, McCrumb FR Jr, Daniel RW, Ozer HL. Serologic evidence for a simian-virus-40-like infection of man. J Natl Cancer Inst 1972;48:557-61.
31. Black PH, Rowe WP. Viral studies of SV40 tumorigenesis in hamsters. J Natl Cancer Inst 1964;32:253-65.
32. Black PH, Rowe WP, Turner HC, Huebner RJ. A specific complement-fixing antigen present in SV40 tumor and transformed cells. Proc Natl Acad Sci U S A 1963;50:1148-56.